🇺🇸 MEDI4736 in United States

483 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pneumonia — 91 reports (18.84%)
  2. Febrile Neutropenia — 61 reports (12.63%)
  3. Pyrexia — 61 reports (12.63%)
  4. Vomiting — 48 reports (9.94%)
  5. Diarrhoea — 43 reports (8.9%)
  6. Pneumonitis — 38 reports (7.87%)
  7. Dyspnoea — 37 reports (7.66%)
  8. Drug-Induced Liver Injury — 36 reports (7.45%)
  9. Colitis — 35 reports (7.25%)
  10. Acute Kidney Injury — 33 reports (6.83%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is MEDI4736 approved in United States?

MEDI4736 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for MEDI4736 in United States?

MedImmune LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.